Navidea Biopharmaceuticals Stock Three Year Return
Navidea Biopharmaceuticals fundamentals help investors to digest information that contributes to Navidea Biopharmaceutica's financial success or failures. It also enables traders to predict the movement of Navidea Pink Sheet. The fundamental analysis module provides a way to measure Navidea Biopharmaceutica's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Navidea Biopharmaceutica pink sheet.
Navidea |
Navidea Biopharmaceuticals Company Three Year Return Analysis
Navidea Biopharmaceutica's Tree Year Return shows the total annualized return generated from holding a fund or ETFs for the last three years. The return measure includes capital appreciation, losses, dividends paid, and all capital gains distributions. This return indicator is considered by many investors to be solid measures of fund mid-term performance.
More About Three Year Return | All Equity Analysis
Three Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although Three Year Fund Return indicator can give a sense of overall fund mid-term potential, it is recommended to compare fund performances against other similar funds, ETFs, or market benchmarks for the same 3 year interval.
CompetitionBased on the latest financial disclosure, Navidea Biopharmaceuticals has a Three Year Return of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Financial Widgets Now
Financial WidgetsEasily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
| All Next | Launch Module |
Navidea Fundamentals
| Return On Equity | -11.0 | ||||
| Return On Asset | -1.22 | ||||
| Current Valuation | 3.5 M | ||||
| Shares Outstanding | 100.08 M | ||||
| Shares Owned By Insiders | 35.43 % | ||||
| Shares Owned By Institutions | 1.50 % | ||||
| Number Of Shares Shorted | 2.69 M | ||||
| Price To Earning | 0.53 X | ||||
| Price To Book | 8.16 X | ||||
| Price To Sales | 84.14 X | ||||
| Revenue | 65.65 K | ||||
| Gross Profit | (119.3 K) | ||||
| EBITDA | (14.05 M) | ||||
| Net Income | (15.18 M) | ||||
| Cash And Equivalents | 328.01 K | ||||
| Cash Per Share | 0.01 X | ||||
| Total Debt | 2.43 M | ||||
| Debt To Equity | 1.20 % | ||||
| Current Ratio | 0.22 X | ||||
| Book Value Per Share | (0.01) X | ||||
| Cash Flow From Operations | (8.99 M) | ||||
| Short Ratio | 0.52 X | ||||
| Earnings Per Share | (0.39) X | ||||
| Target Price | 5.0 | ||||
| Number Of Employees | 11 | ||||
| Beta | 1.5 | ||||
| Market Capitalization | 8.04 M | ||||
| Total Asset | 4.37 M | ||||
| Retained Earnings | (388 M) | ||||
| Working Capital | (6.74 M) | ||||
| Current Asset | 12.58 M | ||||
| Current Liabilities | 6.18 M | ||||
| Net Asset | 4.37 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Consideration for investing in Navidea Pink Sheet
If you are still planning to invest in Navidea Biopharmaceutica check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Navidea Biopharmaceutica's history and understand the potential risks before investing.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |